Generation bio to participate in the bmo biopharma spotlight series: novel technologies for the delivery of genetic medicines

Cambridge, mass., march 21, 2023 (globe newswire) -- generation bio co. (nasdaq:gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in the novel lnps targeting diverse tissues panel at the bmo biopharma spotlight series: novel technologies for the delivery of genetic medicines, which will take place virtually on tuesday, march 28th at 10:00 a.m. et.
GBIO Ratings Summary
GBIO Quant Ranking